Jenburkt Pharmaceuticals Share Price Live
Live Jenburkt Pharmaceuticals Share Price Chart
Jenburkt Pharmaceuticals Performance
Days Range
| Previous Close | ₹1,104.45 |
|---|---|
| Open | ₹1,056.3 |
| Volume | 6,706 |
| Day's Range | ₹1,011.10 - ₹1,099.95 |
|---|---|
| 52W Range | ₹936.70 - ₹1,410.00 |
| Market Cap | ₹487.43 Cr |
Jenburkt Pharmaceuticals Fundamentals
| ROCE(TTM) | 24.68 |
|---|---|
| P/E Ratio (TTM) | 14.77 |
| P/B Ratio | 2.67 |
| Industry P/E | 40.10 |
| Debt to Equity | 0.01 |
| ROE | 18.04 |
| EPS (TTM) | 74.77 |
| Dividend Yield | 1.63 |
| Book Value | 414.39 |
| Face Value | 10 |
| ROCE(TTM) | 24.68 |
|---|---|
| P/E Ratio (TTM) | 14.77 |
| P/B Ratio | 2.67 |
| Industry P/E | 40.10 |
| Debt to Equity | 0.01 |
| ROE | 18.04 |
|---|---|
| EPS (TTM) | 74.77 |
| Dividend Yield | 1.63 |
| Book Value | 414.39 |
| Face Value | 10 |
Jenburkt Pharmaceuticals Financials
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|
| Net Sales | 41.05 | 35.53 | 45.56 | 43.02 |
| Expenses | 30.98 | 27.29 | 33.20 | 36.43 |
| Profit before tax | 11.84 | 10.18 | 14.33 | 8.30 |
| Operating Profit | 8.54 | 7.79 | 10.16 | 5.93 |
| Net Profit | 8.54 | 7.79 | 10.16 | 5.93 |
| EPS in Rs | 19.34 | 17.66 | 23.03 | 13.44 |
Jenburkt Pharmaceuticals Shareholding Pattern
| Held by | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 46.69% | 46.68% | 46.67% | 46.66% | 46.65% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% |
| Public | 53.2% | 53.2% | 53.22% | 53.22% | 53.24% |
About Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Ltd., a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family, was formed in 1985.Jenburkt is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange.Jenburkt`s head quarters is located in Mumbai, from where its entire operations are handled.
Parent Organisation
Indian Private
Managing Director
Ashish U Bhuta
Founded
1985
NSE Symbol
Top Mutual Funds Invested in Jenburkt Pharmaceuticals Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,705.1 3.00 (0.18%) | ₹4,08,558.76 | 1,548.0 - 1,851.2 |
| Divis Laboratories Ltd | 6,035.0 -174.00 (-2.80%) | ₹1,64,826.79 | 4,955.0 - 7,071.5 |
| Torrent Pharmaceuticals Ltd | 4,032.4 -13.20 (-0.33%) | ₹1,36,941.79 | 2,886.45 - 4,107.2 |
| Cipla Ltd | 1,328.9 6.10 (0.46%) | ₹1,06,824.96 | 1,281.7 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,239.8 4.40 (0.36%) | ₹1,03,076.85 | 1,020.0 - 1,379.7 |
| Lupin Ltd | 2,201.8 15.90 (0.73%) | ₹99,911.47 | 1,795.2 - 2,226.3 |
Popular stocks
Jenburkt Pharmaceuticals Ltd FAQs
What is the share price of Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) shares?
Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) share price as of February 4, 2026, on NSE is Rs 1078 (NSE) and Rs 1078 (BSE) on BSE.
Can I buy Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) from Angel One?
Yes, You can buy Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
How do I buy Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) from Angel One?
Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) shares.
1. Direct investment: You can buy Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Jenburkt Pharmaceuticals Ltd (Jenburkt Pharmaceuticals Ltd) shares.
What is the market cap of Jenburkt Pharmaceuticals?
The market cap of Jenburkt Pharmaceuticals is Rs. 487.43 Cr. as of 04/02/2026.
What is the current P/E ratio of Jenburkt Pharmaceuticals?
The P/E ratios of Jenburkt Pharmaceuticals is 14.77 as of 04/02/2026.
What is the current PB ratio of Jenburkt Pharmaceuticals?
The PB ratios of Jenburkt Pharmaceuticals is 2.67 as of 04/02/2026.
.jpg)
